Orji, Ikechukwu A. http://orcid.org/0000-0001-5028-5428
Baldridge, Abigail S.
Ikechukwu-Orji, Mercy U.
Banigbe, Bolanle
Eze, Nelson C.
Chopra, Aashima
Omitiran, Kasarachi
Iyer, Guhan
Odoh, Deborah
Alex-Okoh, Morenike
Reng, Rifkatu
Hirschhorn, Lisa R.
Huffman, Mark D.
Ojji, Dike B.
Article History
Received: 15 February 2024
Accepted: 25 June 2024
First Online: 5 July 2024
Declarations
:
: The study was reviewed and approved by the Ethics Committee at the University of Abuja Teaching Hospital (UATH/HREC/PR/2021/012/005) and the Institutional Review Board at Northwestern University (STU00216041). Ethical oversight of the study was provided by the University of Abuja Teaching Hospital Health Research Ethics Committee. The study was also reviewed by the Federal Capital Territory Ethics Committee. The relevant guidelines and regulations of the Declaration of Helsinki were followed in conducting the study, and all the study participants provided written informed consent.
: Not applicable.
: MDH has received travel support from the American Heart Association and World Heart Federation and consulting fees from PwC Switzerland. MDH has an appointment at The George Institute for Global Health, which has a patent, license, and has received investment funding with intent to commercialize fixed-dose combination therapy through its social enterprise business, George Medicines. MDH has pending patents for heart failure polypills. All the other authors declare that they have no competing interests.